Dydrogesterone supplementation in women with threatened preterm delivery-the impact on cytokine profile, hormone profile, and progesterone-induced blocking factor

Journal of Reproductive Immunology

Volumn 92, Issue 1-2, 2011, Pages 103-107

  Hudić, Igor ^a   Szekeres Bartho, Julia ^b   Fatušić, Zlatan ^a   Stray Pedersen, Babill ^c   Dizdarević Hudić, Larisa ^a   Latifagić, Anela ^a   Hotić, Nešad ^a   Kamerić, Lejla ^a   Mandžić, Amer ^a  

^a UNIVERSITY CLINICAL CENTER TUZLA   (Bosnia and Herzegovina)

^b UNIVERSITY OF PÉCS   (Hungary)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Anti inflammatory cytokines; Dydrogesterone; Preterm delivery; Pro inflammatory cytokines; Progesterone; Progesterone induced blocking factor

Indexed keywords

CYTOKINE; DYDROGESTERONE; ESTRADIOL; GAMMA INTERFERON; HEXOPRENALINE; INTERLEUKIN 10; INTERLEUKIN 6; PROGESTERONE; PROGESTERONE DERIVATIVE; PROGESTERONE INDUCED BLOCKING FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOCKING FACTOR; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESTROGEN BLOOD LEVEL; FEMALE; HORMONAL THERAPY; HUMAN; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL;

DIETARY SUPPLEMENTS; DYDROGESTERONE; EMBRYO IMPLANTATION; ESTRADIOL; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; INTERLEUKIN-10; PREGNANCY; PREGNANCY PROTEINS; PREMATURE BIRTH; PROGESTERONE; PROSPECTIVE STUDIES; SUPPRESSOR FACTORS, IMMUNOLOGIC; TH1-TH2 BALANCE; UP-REGULATION;

EID: 81555228578     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2011.08.006     Document Type: Article

References (31)

1. Curry A.E., Vogel I., Drews C., Schendel D., Skogstrand K., Flanders W.D., et al. Mid-pregnancy maternal plasma levels of interleukin 2, 6, 12, TNF-alfa, INF-gamma and granulocyte colony-stimulating factor and spontaneous preterm delivery. Acta Obstet. Gynecol. Scand. 2007, 86:1103-1110.
2. De Fonseca E., Bittar R., Carvalho M., Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am. J. Obstet. Gynecol. 2003, 188:414-419.
3. Elovitz M.A., Mrinalini C. The use of progestational agents for preterm birth: lessons from a mouse model. Am. J. Obstet. Gynecol. 2006, 195:1004-1010.
4. El-Shazly S., Makhseed M., Azizieh F., Raghupathy R. Increased expression of proinflammatory cytokines in placentas of women undergoing spontaneous preterm delivery or premature rupture of membranes. Am. J. Reprod. Immunol. 2004, 52:45-52.
5. Haas D.M Preterm birth. Clin. Evid. 2011, pii: 1404.
6. Hossein H., Mahroo M., Abbas A., Firouzeh A., Nadia H. Cytokine production by peripheral blood mononuclear cells in RM. Cytokine 2004, 28:83-86.
7. Hudić I., FatuŠić Z. Progesterone-induced blocking factor (PIBF) and Th1/Th2 cytokine in women with threatened spontaneous abortion. J. Perinat. Med. 2009, 37:338-342.
8. Hudić I., FatuŠić Z., Szekeres-Bartho J., Balić D., Polgar B., Ljuca D., Dizdarević-Hudić L. Progesterone-induced blocking factor and cytokine profile in women with threatened preterm delivery. Am. J. Reprod. Immunol. 2009, 61:330-337.
9. Kavalier F. Investigation of recurrent miscarriages. BMJ 2005, 331:121-122.
10. Mackenzie R., Walker M., Armson A., Hannah M.E. Am. J. Obstet. Gynecol. 2006, 194:1234-1242.
11. Polgar B., Kispal G., Lachmann M., Paar C., Nagy E., Csere P., et al. Molecular cloning and immunologic characterization of a novel cDNA coding for progesterone-induced blocking factor. J. Immunol. 2003, 171:5956-5963.
12. Polgar B., Nagy E., Miko E., Varga P., Szekeres-Bartho J. Urinary progesterone-induced blocking factor concentration is related to pregnancy outcome. Biol. Reprod. 2004, 71:1699-1705.
13. Raghupathy R. Maternal anti-placental cell-mediated reactivity and spontaneous abortions. Am. J. Reprod. Immunol. 1997, 37:478-484.
14. Raghupathy R., Al Mutawa E., Makhseed M., Azizieh F., Szekeres-Bartho J. Modulation of cytokine production by dydrogesterone in lymphocytes from women with recurrent miscarriage. BJOG 2005, 112:1096-1101.
15. Raghupathy R., Makhseed M., Azizieh F., Omu A., Gupta M., Farhat R. Cytokine production by maternal lymphocytes during normal human pregnancy and in unexplained recurrent spontaneous abortion. Hum. Reprod. 2000, 15:713-718.
16. Raghupathy R., Kalinka J. Cytokine imbalance in pregnancy complications and its modulation. Front. Biosci. 2008, 13:985-994.
17. Raghupathy R., Al-Mutawa E., Al-Azemi M., Makhseed M., Azizieh F., Szekeres-Bartho J. Progesterone-induced blocking factor (PIBF) modulates cytokine production by lymphocytes from women with recurrent miscarriage or preterm delivery. J. Reprod. Immunol. 2009, 80:91-99.
18. Raghupathy R., Makhseed M., Azizieh F., Hassan N., Al-Azemi M., Al-Shamali E. Maternal Th1- and Th2-type reactivity to placental antigens in normal human pregnancy and unexplained recurrent spontaneous abortions. Cell. Immunol. 1999, 196:122-130.
19. Rezaei A., Dabbagh A. T-helper (1) cytokines increase during early pregnancy in women with a history of recurrent spontaneous abortion. Med. Sci. Monit. 2002, 8:607-610.
20. Romero R., Avila C., Santhanam U., Sehgal P.B. Amniotic fluid interleukin-6 in preterm labor association with infection. J. Clin. Invest. 1990, 85:1392-1400.
21. Sanchez-Ramos L., Kaunitz A.M., Delke I. Progestational agents to prevent preterm birth: a meta-analysis of randomised controlled trials. Obstet. Gynecol. 2005, 105:273-279.
22. Shields A.D., Wright J., Paonessa D.J., Gotkin J., Howard B.C., Hoeldtke N.J., Napolitano P.G. Progesterone modulation of inflammatory cytokine production in a fetoplacental artery explant model. Am. J. Obstet. Gynecol. 2005, 193:1144-1148.
23. Stites D.P., Bugbee S., Siiteri P.K. Differential actions of progesterone and cortisol on lymphocyte and monocyte interaction during lymphocyte activation - relevance to immunosuppression in pregnancy. J. Reprod. Immunol. 1983, 5:215-228.
24. Szekeres-Bartho J., Wegmann T.G. A progesterone-dependent immunomodulatory protein alters the Th1/Th2 balance. J. Reprod. Immunol. 1996, 2:81-95.
25. Szekeres-Bartho J., Faust Z., Varga P., Szereday L., Kelemen K. The immunological pregnancy protective effect of progesterone is manifested via controlling cytokine production. Am. J. Reprod. Immunol. 1996, 35:348-351.
26. Szekeres-Bartho J., Par G., Dombay G., Smart Y.C., Volgyi Z. The anti-abortive effi mice is manifested by modulating NK activity. Cell. Immunol. 1997, 177:194-199.
27. Szekeres-Bartho J., Par G., Szereday L., Smart C.Y., Achacz I. Progesterone and non-specific immunological mechanisms in pregnancy. Am. J. Reprod. Immunol. 1997, 38:176-182.
28. Szereday L., Varga P., Szekeres-Bartho J. Cytokine production by lymphocytes in pregnancy. Am. J. Reprod. Immunol. 1997, 38:418-422.
29. Wegmann T.G., Hui Lin, Guilbert L., Mosmann T.R. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon?. Immunol. Today 1993, 14:353-356.
30. Wilke C., Renz H., Tekesin I., Hellmeyer L., Herz U., Schmidt S. Suppression of IL-2 and INF-gamma production in women with spontaneous preterm labor. J. Perinat. Med. 2006, 34:20-27.
31. Wilson B., Moor J., Jenkins C., Miller H., Walker J., McLean M., Norman J., McInnes I. Abnormal first trimester serum interleukin 18 levels are associated with a poor outcome in women with a history of RM. Am. J. Reprod. Immunol. 2004, 51:156-159.